Duyuru • Apr 22
Atlantic American Corporation Receives Nasdaq Notice Regarding Delayed Form 10-K Filing On April 17, 2026, Atlantic American Corporation (the Company) received a notice (the Notice) from The Nasdaq Stock Market LLC (Nasdaq) stating that because the Company had not yet filed its Annual Report on Form 10-K for the year ended December 31, 2025 (the Form 10-K), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Notice states that the Company has 60 calendar days from the date of the notice to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company's plan, then Nasdaq may grant the Company up to 180 calendar days from the prescribed due date for filing the Form 10-K to regain compliance. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq Hearings Panel. The Notice has no immediate effect on the listing of the Company's common stock on The Nasdaq Global Market. The Company continues to work diligently to file the Form 10-K as promptly as practicable. If the Company is unable to file the Form 10-K within 60 calendar days from the date of the Notice, the Company intends to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. Duyuru • Apr 02
Atlantic American Corporation announced delayed annual 10-K filing On 04/01/2026, Atlantic American Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC. Duyuru • Mar 26
Atlantic American Corporation, Annual General Meeting, May 13, 2025 Atlantic American Corporation, Annual General Meeting, May 13, 2025. Location: at 4370 peachtree road, n.e., atlanta, georgia 30319, United States Duyuru • Mar 26
Atlantic American Corporation Declares Annual Dividend, Payable on April 23, 2025 Atlantic American Corporation announced that Board of Directors has approved the Company’s annual dividend of $0.02per share. This dividend will be payable on April 23, 2025, to shareholders of record as of April 9, 2025. Reported Earnings • May 17
First quarter 2024 earnings released: US$0.10 loss per share (vs US$0.076 loss in 1Q 2023) First quarter 2024 results: US$0.10 loss per share (further deteriorated from US$0.076 loss in 1Q 2023). Revenue: US$47.0m (up 1.6% from 1Q 2023). Net loss: US$2.10m (loss widened 36% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 84 percentage points per year, which is a significant difference in performance. Duyuru • Apr 09
Atlantic American Corporation, Annual General Meeting, May 06, 2024 Atlantic American Corporation, Annual General Meeting, May 06, 2024, at 10:00 Eastern Standard Time. Location: principal executive offices of the Company at 4370 Peachtree Road, N.E Atlanta Georgia United States Agenda: To elect six (6) directors of the company to serve until the next annual meeting of shareholders and until their successors are duly elected and qualified; to ratify the appointment of forvis, llp as the company’s independent registered public accounting firm for the fiscal year ending december 31, 2024; and to transact such other business as may properly come before the meeting or any adjournments or postponements thereof. Reported Earnings • Apr 02
Full year 2023 earnings released: US$0.028 loss per share (vs US$0.055 profit in FY 2022) Full year 2023 results: US$0.028 loss per share (down from US$0.055 profit in FY 2022). Revenue: US$186.8m (flat on FY 2022). Net loss: US$570.0k (down 151% from profit in FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Duyuru • Apr 02
Atlantic American Corporation Declares Annual Dividend for the Year 2023, Payable on April 26, 2024 Atlantic American Corporation declared annual dividend of $0.02 per share, which is payable on April 26, 2024 to shareholders of record on April 12, 2024 for the year 2023. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to US$2.45, the stock trades at a trailing P/E ratio of 18.5x. Average trailing P/E is 13x in the Insurance industry in the US. Total returns to shareholders of 22% over the past three years. Valuation Update With 7 Day Price Move • Nov 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to US$1.83, the stock trades at a trailing P/E ratio of 13.8x. Average trailing P/E is 13x in the Insurance industry in the US. Total loss to shareholders of 14% over the past three years. Reported Earnings • Nov 16
Third quarter 2023 earnings released: EPS: US$0.08 (vs US$0.038 loss in 3Q 2022) Third quarter 2023 results: EPS: US$0.08 (up from US$0.038 loss in 3Q 2022). Revenue: US$44.6m (down 3.8% from 3Q 2022). Net income: US$1.66m (up US$2.44m from 3Q 2022). Profit margin: 3.7% (up from net loss in 3Q 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 64 percentage points per year, which is a significant difference in performance. Board Change • Aug 22
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 5 highly experienced directors. Independent Director Mark Preisinger was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Aug 09
Atlantic American Corporation Declares Annual Dividend, Payable on September 12, 2023 Atlantic American Corporation Board of Directors recently approved the Company’s annual dividend of $0.02 per share, which is payable on September 12, 2023 to shareholders of record on August 22, 2023. Duyuru • Jul 01
Atlantic American Corporation, Annual General Meeting, Aug 08, 2023 Atlantic American Corporation, Annual General Meeting, Aug 08, 2023, at 10:00 US Eastern Standard Time. Location: 4370 Peachtree Road, N.E., Atlanta Georgia United States Agenda: To elect six directors of the company to serve until the next annual meeting of shareholders and until their successors are duly elected and qualified; to ratify the appointment of Forvis, Llp as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2023; and to transact such other business as may properly come before the meeting or any adjournments or postponements thereof. Board Change • Nov 16
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Independent Director Mark Preisinger was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 09
Third quarter 2022 earnings released: US$0.04 loss per share (vs US$0.05 loss in 3Q 2021) Third quarter 2022 results: US$0.04 loss per share (improved from US$0.05 loss in 3Q 2021). Revenue: US$46.3m (down 6.0% from 3Q 2021). Net loss: US$684.0k (loss narrowed 33% from 3Q 2021). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 13
Second quarter 2022 earnings released: US$0.09 loss per share (vs US$0.14 profit in 2Q 2021) Second quarter 2022 results: US$0.09 loss per share (down from US$0.14 profit in 2Q 2021). Revenue: US$44.7m (down 13% from 2Q 2021). Net loss: US$1.68m (down 159% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 64% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 08
Investor sentiment improved over the past week After last week's 20% share price gain to US$3.06, the stock trades at a trailing P/E ratio of 8.7x. Average trailing P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 35% over the past three years. Valuation Update With 7 Day Price Move • May 31
Investor sentiment improved over the past week After last week's 18% share price gain to US$3.14, the stock trades at a trailing P/E ratio of 9x. Average trailing P/E is 12x in the Insurance industry in the US. Total returns to shareholders of 34% over the past three years. Reported Earnings • May 13
First quarter 2022 earnings released: EPS: US$0.14 (vs US$0.026 loss in 1Q 2021) First quarter 2022 results: EPS: US$0.14 (up from US$0.026 loss in 1Q 2021). Revenue: US$51.6m (up 5.2% from 1Q 2021). Net income: US$2.74m (up US$3.27m from 1Q 2021). Profit margin: 5.3% (up from net loss in 1Q 2021). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 8% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Insufficient new directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. 3 highly experienced directors. Independent Director Mark Preisinger was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Duyuru • Apr 16
Atlantic American Corporation, Annual General Meeting, May 24, 2022 Atlantic American Corporation, Annual General Meeting, May 24, 2022, at 10:00 US Eastern Standard Time. Location: principal executive offices of the Company at 4370 Peachtree Road, N.E. Atlanta Georgia United States Agenda: To elect six directors of the company to serve until the next annual meeting of shareholders and until their successors are duly elected and qualified; to ratify the appointment of Dixon Hughes Goodman LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2022; to approve, on an advisory basis, the compensation of our named executive officers; to approve the company’s 2022 equity and incentive compensation plan; and to transact such other business as may properly come before the meeting or any adjournments or postponements thereof. Upcoming Dividend • Apr 05
Upcoming dividend of US$0.02 per share Eligible shareholders must have bought the stock before 12 April 2022. Payment date: 27 April 2022. Payout ratio is a comfortable 11% and the cash payout ratio is 82%. Trailing yield: 0.6%. Lower than top quartile of American dividend payers (3.7%). Lower than average of industry peers (2.0%). Reported Earnings • Mar 28
Full year 2021 earnings released: EPS: US$0.19 (vs US$0.58 in FY 2020) Full year 2021 results: EPS: US$0.19 (down from US$0.58 in FY 2020). Revenue: US$199.6m (up 2.2% from FY 2020). Net income: US$3.88m (down 67% from FY 2020). Profit margin: 1.9% (down from 6.0% in FY 2020). The decrease in margin was driven by higher expenses. Combined ratio: 105.0% (up from 94.7% in FY 2020). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Mar 22
Investor sentiment improved over the past week After last week's 15% share price gain to US$2.62, the stock trades at a trailing P/E ratio of 4.1x. Average trailing P/E is 11x in the Insurance industry in the US. Negligible returns to shareholders over past three years. Valuation Update With 7 Day Price Move • Jan 22
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$2.28, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 11x in the Insurance industry in the US. Total loss to shareholders of 13% over the past three years. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment improved over the past week After last week's 18% share price gain to US$2.90, the stock trades at a trailing P/E ratio of 4.5x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 13% over the past three years. Valuation Update With 7 Day Price Move • Dec 21
Investor sentiment deteriorated over the past week After last week's 15% share price decline to US$3.12, the stock trades at a trailing P/E ratio of 4.9x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 33% over the past three years. Reported Earnings • Nov 12
Third quarter 2021 earnings released: US$0.05 loss per share (vs US$0.087 profit in 3Q 2020) The company reported a soft third quarter result with weaker earnings and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: US$49.3m (up 6.5% from 3Q 2020). Net loss: US$915.0k (down 152% from profit in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 01
Investor sentiment improved over the past week After last week's 18% share price gain to US$4.35, the stock trades at a trailing P/E ratio of 5.6x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 55% over the past three years. Valuation Update With 7 Day Price Move • Aug 17
Investor sentiment deteriorated over the past week After last week's 21% share price decline to US$3.54, the stock trades at a trailing P/E ratio of 4.6x. Average trailing P/E is 10x in the Insurance industry in the US. Total returns to shareholders of 41% over the past three years. Reported Earnings • Aug 12
Second quarter 2021 earnings released: EPS US$0.14 (vs US$0.32 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: US$51.5m (up 3.5% from 2Q 2020). Net income: US$2.86m (down 56% from 2Q 2020). Profit margin: 5.6% (down from 13% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment deteriorated over the past week After last week's 16% share price decline to US$3.93, the stock trades at a trailing P/E ratio of 4.1x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 66% over the past three years. Valuation Update With 7 Day Price Move • Jun 03
Investor sentiment improved over the past week After last week's 17% share price gain to US$5.00, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 11x in the Insurance industry in the US. Total returns to shareholders of 84% over the past three years. Upcoming Dividend • Apr 05
Upcoming dividend of US$0.02 per share Eligible shareholders must have bought the stock before 12 April 2021. Payment date: 27 April 2021. Trailing yield: 0.5%. Lower than top quartile of American dividend payers (3.5%). Lower than average of industry peers (2.5%). Valuation Update With 7 Day Price Move • Mar 31
Investor sentiment deteriorated over the past week After last week's 30% share price decline to US$3.59, the stock trades at a trailing P/E ratio of 6.2x. Average trailing P/E is 14x in the Insurance industry in the US. Total returns to shareholders of 10% over the past three years. Reported Earnings • Mar 25
Full year 2020 earnings released: EPS US$0.58 (vs US$0.039 loss in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were weaker. Full year 2020 results: Revenue: US$195.3m (down 1.4% from FY 2019). Net income: US$11.8m (up US$12.6m from FY 2019). Profit margin: 6.0% (up from net loss in FY 2019). The move to profitability was driven by lower expenses. Combined ratio: 94.7% (down from 109.8% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment deteriorated over the past week After last week's 18% share price decline to US$3.67, the stock is trading at a trailing P/E ratio of 63x, down from the previous P/E ratio of 76.7x. This compares to an average P/E of 15x in the Insurance industry in the US. Total returns to shareholders over the past three years are 11%. Valuation Update With 7 Day Price Move • Feb 20
Investor sentiment deteriorated over the past week After last week's 19% share price decline to US$4.64, the stock is trading at a trailing P/E ratio of 79.6x, down from the previous P/E ratio of 98x. This compares to an average P/E of 14x in the Insurance industry in the US. Total returns to shareholders over the past three years are 34%. Is New 90 Day High Low • Feb 06
New 90-day high: US$5.20 The company is up 142% from its price of US$2.15 on 06 November 2020. The American market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 14% over the same period. Valuation Update With 7 Day Price Move • Jan 09
Investor sentiment improved over the past week After last week's 17% share price gain to US$2.41, the stock is trading at a trailing P/E ratio of 41.4x, up from the previous P/E ratio of 35.4x. This compares to an average P/E of 14x in the Insurance industry in the US. Total return to shareholders over the past three years is a loss of 27%. Valuation Update With 7 Day Price Move • Jan 06
Investor sentiment improved over the past week After last week's 24% share price gain to US$2.60, the stock is trading at a trailing P/E ratio of 44.6x, up from the previous P/E ratio of 36x. This compares to an average P/E of 14x in the Insurance industry in the US. Total return to shareholders over the past three years is a loss of 22%. Is New 90 Day High Low • Jan 06
New 90-day high: US$2.60 The company is up 30% from its price of US$2.00 on 07 October 2020. The American market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 13% over the same period. Is New 90 Day High Low • Dec 15
New 90-day high: US$2.32 The company is up 15% from its price of US$2.01 on 15 September 2020. The American market is up 10.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Insurance industry, which is up 12% over the same period. Reported Earnings • Nov 12
Third quarter 2020 earnings released: EPS US$0.09 The company reported a decent third quarter result with improved earnings and profit margins, although revenues were weaker. Third quarter 2020 results: Revenue: US$46.3m (down 3.1% from 3Q 2019). Net income: US$1.78m (up US$3.27m from 3Q 2019). Profit margin: 3.8% (up from net loss in 3Q 2019). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 75% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings.